Advances in prodrug design for Alzheimer’s disease: the state of the art-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Advances in prodrug design for Alzheimer’s disease: the state of the art

Published:2022-02-23 Issue:4 Volume:17 Page:325-341
ISSN:1746-0441
Container-title:Expert Opinion on Drug Discovery
language:en
Short-container-title:Expert Opinion on Drug Discovery

Author:

Travers--Lesage Valentin¹^ORCID,Mignani Serge M.²³^ORCID,Dallemagne Patrick¹^ORCID,Rochais Christophe¹^ORCID

Affiliation:

1. Normandie Univ, UNICAEN, Centre d’Etudes et de Recherche sur le Médicament de Normandie (CERMN), Caen, France

2. UMR 860, Laboratoire de Chimie et de Biochimie Pharmacologiques et Toxicologique, Université Paris Descartes, PRES Sorbonne Paris Cité, CNRS, 45 rue des Saints Pères, 75006 Paris, France

3. CQM – Centro de Química da Madeira, MMRG, Universidade da Madeira, Campus da Penteada, 9020-105 Funchal, Portugal

Funder

French Agence Nationale de la Recherche

Publisher

Informa UK Limited

Subject

Drug Discovery

Link

https://www.tandfonline.com/doi/pdf/10.1080/17460441.2022.2031972

Reference97 articles.

1. Alzheimer's Disease: The Amyloid Cascade Hypothesis

2. Alzheimer's disease drug development pipeline: 2019

3. The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 31st Annual GP2A Medicinal Chemistry Conference;Drugs and Drug Candidates;2024-02-22

2. Recent advance on carbamate-based cholinesterase inhibitors as potential multifunctional agents against Alzheimer's disease;European Journal of Medicinal Chemistry;2022-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP